Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius Rademaker

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
BMC Complementary Medicine and Therapies|January 29, 2024
Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New ZealandGabrielle Shortt, Nicholas Shortt, Georgina Bird, et al.
The Australasian Journal of Dermatology|May 14, 2025
Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology GroupMarius Rademaker, Peter Foley, Katherine Armour, et al.
The British Journal of Dermatology|June 28, 2025
Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up)Melinda Gooderham, Tiago Torres, Shinichi Imafuku, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 11, 2024
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitisJonathan I Silverberg, Melinda Gooderham, Norito Katoh, et al.
The Australasian Journal of Dermatology|March 11, 2015
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statementEmma Mooney, Marius Rademaker, Rebecca Dailey, et al.
Narra J|March 7, 2024
Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, IndonesiaMuhammad A Rayhan, Mudatsir Mudatsir, Nurjannah Nurjannah, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Narra J|March 7, 2024
Acute severe hepatitis of unknown etiology in children: A mini-reviewAndri Frediansyah, Malik Sallam, Amanda Yufika, et al.
Narra J|March 7, 2024
Monkeypox: Immune response, vaccination and preventive effortsYoudiil Ophinni, Andri Frediansyah, Salin Sirinam, et al.
Journal of Paediatrics and Child Health|June 1, 2026
Development of Multidisciplinary Consensus-Informed Guidance for the Management of Paediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Clinicians From Australasian Tertiary Referral HospitalsPatrick David Mahar, Thomas Lee, David Orchard, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
BMC Complementary Medicine and Therapies|January 29, 2024
Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New ZealandGabrielle Shortt, Nicholas Shortt, Georgina Bird, et al.
The Australasian Journal of Dermatology|May 14, 2025
Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology GroupMarius Rademaker, Peter Foley, Katherine Armour, et al.
The British Journal of Dermatology|June 28, 2025
Efficacy and Safety of Upadacitinib Dose Escalation and Reduction in Adult Patients With Moderate-To-Severe Atopic Dermatitis: Results of a Randomized, Blinded, Treat-To-Target, Multicenter Phase 3b/4 Study (Flex Up)Melinda Gooderham, Tiago Torres, Shinichi Imafuku, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 11, 2024
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitisJonathan I Silverberg, Melinda Gooderham, Norito Katoh, et al.
The Australasian Journal of Dermatology|March 11, 2015
Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statementEmma Mooney, Marius Rademaker, Rebecca Dailey, et al.
Narra J|March 7, 2024
Acceptance and willingness to purchase a hypothetical COVID-19 vaccine in a region under Shariah law: A cross-sectional study in Aceh, IndonesiaMuhammad A Rayhan, Mudatsir Mudatsir, Nurjannah Nurjannah, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Narra J|March 7, 2024
Acute severe hepatitis of unknown etiology in children: A mini-reviewAndri Frediansyah, Malik Sallam, Amanda Yufika, et al.
Narra J|March 7, 2024
Monkeypox: Immune response, vaccination and preventive effortsYoudiil Ophinni, Andri Frediansyah, Salin Sirinam, et al.
Journal of Paediatrics and Child Health|June 1, 2026
Development of Multidisciplinary Consensus-Informed Guidance for the Management of Paediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Clinicians From Australasian Tertiary Referral HospitalsPatrick David Mahar, Thomas Lee, David Orchard, et al.
Pageof 11